Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Schneider National
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Automation, Cost Pressures And Regulatory Hurdles Will Erode Value
Key Takeaways Advances in automation and digital logistics threaten Schneider's traditional trucking business and risk market share loss to more agile, tech-focused competitors. Slower fleet electrification and heavy reliance on long-haul operations expose Schneider to higher costs, competitive pressure, and eroding pricing power.
View narrative
US$23.00
FV
6.2% overvalued
intrinsic discount
5.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Organon
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Global Pricing Pressures And Patent Cliffs Will Weaken Margins
Key Takeaways Intensifying price controls, loss of product exclusivity, and weak innovation constrain revenue, margin, and growth prospects amid rising generic rivalry and regulatory scrutiny. Substantial debt obligations and global trade risks limit investment capacity, elevate operational costs, and threaten future profitability and cash flow stability.
View narrative
US$9.00
FV
3.1% overvalued
intrinsic discount
-0.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Exelixis
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Regulatory Uncertainty And 340B Pressures Will Erode Oncology Margins
Key Takeaways Increasing regulatory scrutiny, payer discounts, and reliance on a single franchise threaten margins, revenue stability, and overall profitability. Rising R&D costs and intensifying competition in oncology create risks to market share, product relevance, and sustained earnings growth.
View narrative
US$36.00
FV
7.5% overvalued
intrinsic discount
4.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
13 days ago
author updated this narrative
Open Text
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Legacy Decline And Acquisition Risks Will Shadow Future Value
Key Takeaways Persistent weakness in legacy products, modest cloud growth, and intense price competition threaten long-term revenue and margin expansion. Heavy dependence on acquisitions and pressures from regulatory, technological, and hyperscaler shifts heighten operational and strategic risks.
View narrative
US$28.00
FV
14.0% overvalued
intrinsic discount
0.075%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Knight-Swift Transportation Holdings
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Declining Freight Demand And Cost Pressures Will Overwhelm Profit Margins
Key Takeaways Shifting market dynamics and competition from e-commerce and tech-driven logistics platforms threaten core revenue streams and undermine pricing power. Rising environmental regulation and complex acquisitions elevate costs and operational risks, constraining cash flow, profitability, and investment flexibility.
View narrative
US$43.00
FV
0.7% undervalued
intrinsic discount
4.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Eastman Chemical
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Asian Dumping And Tariffs Will Crimp Chemical Margins
Key Takeaways Exposure to trade restrictions, anti-plastic mandates, and aggressive Asian competition threatens demand, pricing power, and global market share across key business segments. Substantial capital and regulatory costs, environmental liabilities, and declining margins may limit cash flow, earnings growth, and overall financial resilience.
View narrative
US$60.00
FV
10.0% overvalued
intrinsic discount
-1.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
13 days ago
author updated this narrative
Ryan Specialty Holdings
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
AI Automation And Compliance Costs Will Depress Broker Margins
Key Takeaways Advancing automation, regulatory pressures, and insurtech competition threaten margins, curb organic growth, and risk eroding Ryan Specialty Holdings' core value proposition. Persistently weak insurance cycles and escalating systemic risks reduce commission revenues, compress the addressable market, and undermine overall earnings stability.
View narrative
US$60.00
FV
0.3% undervalued
intrinsic discount
15.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Blue Owl Capital
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Fee Compression And Regulatory Burdens Will Erode Alternative Models
Key Takeaways Shifts toward passive investing and fee compression threaten Blue Owl's traditional revenue streams, increasing structural fundraising and margin challenges. Regulatory changes, integration risks from acquisitions, and rising bond yields could elevate costs, complicate operations, and slow future growth.
View narrative
US$17.31
FV
7.2% overvalued
intrinsic discount
15.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
AAON
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
HVAC Regulatory Woes Will Squeeze Margins Yet Spark Recovery
Key Takeaways Elevated costs and inefficiencies from aggressive expansion and new facilities are straining near-term margins and cash flow despite long-term margin improvement efforts. Heavy dependence on data center customers and the North American market increases exposure to market volatility and regional economic headwinds, threatening growth stability.
View narrative
US$90.00
FV
10.1% undervalued
intrinsic discount
15.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Value any company in seconds
Popular companies